Public Drug Program Formulary Tables – Psoriasis and Psoriatic Arthritis

Province	Class	Generic Name	Drug Name	Psoriasis	Psoriatic Arthritis
Alberta	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Alberta	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
Alberta	Biologics and Biosimilars	Adalimumab	Humira®	No	No
Alberta	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - S/A	Yes - S/A
Alberta	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - S/A	Yes - S/A
Alberta	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - S/A	Yes - S/A
Alberta	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - S/A	Yes - S/A
Alberta	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - S/A	Yes - S/A
Alberta	Biologics and Biosimilars	Adalimumab	Abrilada	Yes – S/A	Yes – S/A
Alberta	Biologics and Biosimilars	Adalimumab	Simlandi	Yes – S/A	Yes – S/A
Alberta	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes – S/A	Yes – S/A
Alberta	Systemic Drugs	Apremilast	Otezla®	No	No
Alberta	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes – S/A	No
Alberta	Biologics and Biosimilars	Brodalumab	Siliq™	No	N/A
Alberta	Systemic Drugs	Celecoxib	Celebrex	No	No
Alberta	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – S/A
Alberta	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
Alberta	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
Alberta	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
Alberta	Systemic Drugs	Cyclosporine		Yes – S/A	N/A
Alberta	Biologics and Biosimilars	Etanercept	Enbrel®	No	No
Alberta	Biologics and Biosimilars	Etanercept	Erelzi™	Yes – S/A	Yes – S/A
Alberta	Biologics and Biosimilars	Etanercept	Brenzys®	Yes – S/A	Yes – S/A
Alberta	Biologics and Biosimilars	Etanercept	Rymti	Yes - S/A	Yes - S/A
Alberta	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – S/A
Alberta	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes - S/A	Yes - S/A
Alberta	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes - S/A	N/A
Alberta	Biologics and Biosimilars	Infliximab	Remicade®	No	No
Alberta	Biologics and Biosimilars	Infliximab	Avsola®	Yes – S/A	Yes – S/A
Alberta	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – S/A	Yes – S/A
British Columbia	Biologics and Biosimilars	Abatacept	Orencia®	No	No
British Columbia	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
British Columbia	Biologics and Biosimilars	Adalimumab	Humira®	No – S/A requests for psoriasis patients who are unable to transition to biosimilar could be considered on an exceptional case-by-case basis.	No – S/A requests for psoriatic arthritis patients who are unable to transition to biosimilar could be considered on an exceptional case-by-case basis.
British Columbia	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - S/A	Yes - S/A
British Columbia	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - S/A	Yes - S/A
British Columbia	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - S/A	Yes - S/A
British Columbia	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - S/A	Yes - S/A
British Columbia	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - S/A	Yes - S/A
British Columbia	Biologics and Biosimilars	Adalimumab	Abrilada	Yes - S/A	Yes - S/A
British Columbia	Biologics and Biosimilars	Adalimumab	Simlandi	Yes - S/A	Yes - S/A
British Columbia	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes - S/A	Yes - S/A
British Columbia	Systemic Drugs	Apremilast	Otezla®	No	No
British Columbia	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes - S/A	No
British Columbia	Biologics and Biosimilars	Brodalumab	Siliq™	No	N/A
British Columbia	Systemic Drugs	Celecoxib	Celebrex	No	Yes – S/A
British Columbia	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes - S/A
British Columbia	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
British Columbia	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	No	N/A
British Columbia	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	No	N/A
British Columbia	Systemic Drugs	Cyclosporine		Yes – S/A	N/A
British Columbia	Biologics and Biosimilars	etanercept	Enbrel®	No – S/A requests for psoriasis patients who are unable to transition to biosimilar could be considered on an exceptional case-by-case basis.	No – S/A requests for psoriatic arthritis patients who are unable to transition to biosimilar could be considered on an exceptional case-by-case basis.
British Columbia	Biologics and Biosimilars	Etanercept	Erelzi™	Yes - S/A	Yes – S/A
British Columbia	Biologics and Biosimilars	Etanercept	Brenzys®	Yes - S/A	Yes – S/A
British Columbia	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – S/A
British Columbia	Biologics and Biosimilars	Guselkumab	Tremfya®	No	No
British Columbia	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	No	N/A
British Columbia	Biologics and Biosimilars	Infliximab	Remicade®	No	No
British Columbia	Biologics and Biosimilars	Infliximab	Avsola®	Yes – S/A	Yes – S/A
British Columbia	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – S/A	Yes – S/A
Manitoba	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Manitoba	Systemic Drugs	Acitretin	Soriatane®, Mint-Acitretin, Taro-Acitretin	Yes	N/A
Manitoba	Biologics and Biosimilars	Adalimumab	Humira®	Yes - EDS. Hadlima, Hyrimoz, Idacio, Amgevita or Idacio will be the preferred adalimumab option for all adalimumab-naïve patients prescribed an adalimumab product for psoriasis.	Yes - EDS. Hadlima, Hyrimoz, Idacio, Amgevita or Idacio will be the preferred adalimumab option for all adalimumab-naïve patients prescribed an adalimumab product for psoriatic arthritis.
Manitoba	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Adalimumab	Abrilada	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Adalimumab	Simlandi	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes - EDS	Yes - EDS
Manitoba	Systemic Drugs	Apremilast	Otezla®	No	No
Manitoba	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes - EDS	No
Manitoba	Systemic Drugs	Celecoxib	Celebrex, Celecoxib	Yes	Yes
Manitoba	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – EDS
Manitoba	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
Manitoba	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
Manitoba	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
Manitoba	Systemic Drugs	Cyclosporine	Requires EDS, delete this row?	Yes	N/A
Manitoba	Systemic Drugs	Cyclosporine	Neoral, Cyclosporine(Strides), Sandoz Cyclosporine	Yes – EDS	N/A
Manitoba	Biologics and Biosimilars	Etanercept	Enbrel®	Yes – EDS. Erelzi or Brenzys will be the preferred etanercept option for all etanercept-naïve patients prescribed an etanercept product for psoriasis.	Yes – EDS. Erelzi or Brenzys will be the preferred etanercept option for all etanercept-naïve patients prescribed an etanercept product for psoriatic arthritis.
Manitoba	Biologics and Biosimilars	Etanercept	Erelzi™	Yes – EDS	Yes – EDS
Manitoba	Biologics and Biosimilars	Etanercept	Brenzys®	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – EDS
Manitoba	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes - EDS	Yes - EDS
Manitoba	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes	N/A
Manitoba	Biologics and Biosimilars	Infliximab	Remicade®	Yes – EDS. Inflectra, Renflexis or Avsola will be the preferred infliximab option for all infliximab-naïve patients prescribed an infliximab product.	Yes – EDS. Inflectra, Renflexis or Avsola will be the preferred infliximab option for all infliximab-naïve patients prescribed an infliximab product.
Manitoba	Biologics and Biosimilars	Infliximab	Avsola®	Yes - EDS	Yes - EDS
Manitoba	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – EDS	Yes – EDS
New Brunswick	Biologics and Biosimilars	Abatacept	Orencia®	No	No
New Brunswick	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
New Brunswick	Biologics and Biosimilars	Adalimumab	Humira®	No	No
New Brunswick	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Adalimumab	Abrilada	Yes – S/A	Yes – S/A
New Brunswick	Biologics and Biosimilars	Adalimumab	Simlandi	Yes – S/A	Yes – S/A
New Brunswick	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes – S/A	Yes – S/A
New Brunswick	Systemic Drugs	Apremilast	Otezla®	No	No
New Brunswick	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes – S/A	No
New Brunswick	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – S/A	N/A
New Brunswick	Systemic Drugs	Celecoxib	Celebrex	N/A	Yes
New Brunswick	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – S/A
New Brunswick	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
New Brunswick	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
New Brunswick	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
New Brunswick	Systemic Drugs	Cyclosporine		Yes	N/A
New Brunswick	Biologics and Biosimilars	Etanercept	Enbrel®	No	No
New Brunswick	Biologics and Biosimilars	Etanercept	Erelzi™	Yes – S/A	Yes – S/A
New Brunswick	Biologics and Biosimilars	Etanercept	Brenzys®	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Etanercept	Rymti	Yes – S/A	Yes – S/A
New Brunswick	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – S/A
New Brunswick	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes – S/A	Yes – S/A
New Brunswick	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes	N/A
New Brunswick	Biologics and Biosimilars	Infliximab	Remicade®	No	No
New Brunswick	Biologics and Biosimilars	Infliximab	Avsola®	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Infliximab	Inflectra®	Yes - S/A	Yes - S/A
Newfoundland and Labrador	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Newfoundland and Labrador	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Humira®	Yes - S/A All SA requests for coverage of adalimumab for adalimumab- naïve patients will be assessed for the biosimilars of adalimumab only. Patients whose initial Special Authority was received before April 17, 2021 will be eligible for coverage of Humira.	Yes - S/A All SA requests for coverage of adalimumab for adalimumab- naïve patients will be assessed for the biosimilars of adalimumab only. Patients whose initial Special Authority was received before April 17, 2021 will be eligible for coverage of Humira.
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - S/A	Yes - S/A
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - S/A	Yes - S/A
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - S/A	Yes - S/A
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - S/A	Yes - S/A
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - S/A	Yes - S/A
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Abrilada	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Simlandi	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Systemic Drugs	Apremilast	Otezla®	No	No
Newfoundland and Labrador	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes – S/A	No
Newfoundland and Labrador	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – S/A	N/A
Newfoundland and Labrador	Systemic Drugs	Celecoxib		N/A	Yes
Newfoundland and Labrador	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – S/A
Newfoundland and Labrador	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes – S/A	N/A
Newfoundland and Labrador	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	No	N/A
Newfoundland and Labrador	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
Newfoundland and Labrador	Systemic Drugs	Cyclosporine		Yes	N/A
Newfoundland and Labrador	Biologics and Biosimilars	Etanercept	Enbrel®	No	No
Newfoundland and Labrador	Biologics and Biosimilars	Etanercept	Erelzi™	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Biologics and Biosimilars	Etanercept	Brenzys®	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – S/A
Newfoundland and Labrador	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes – S/A	N/A
Newfoundland and Labrador	Biologics and Biosimilars	Infliximab	Remicade®	Yes – S/A; Inflectra or Renflexis are the preferred infliximab therapy for treatment naïve patients (coverage will only be considered for Remicade in patients stabilized prior to June 1, 2016).	No
Newfoundland and Labrador	Biologics and Biosimilars	Infliximab	Avsola®	Yes - S/A	Yes - SA
Newfoundland and Labrador	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – S/A	Yes – S/A
NIHB	Biologics and Biosimilars	Abatacept	Orencia®	No	No
NIHB	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
NIHB	Biologics and Biosimilars	Adalimumab	Humira®	Yes- only for clients who received approval for Humira before June 11, 2021	Yes- only for clients who received approval for Humira before June 11, 2021
NIHB	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - L/U	Yes - L/U
NIHB	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - L/U	Yes - L/U
NIHB	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - L/U	Yes - L/U
NIHB	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - L/U	Yes - L/U
NIHB	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - L/U	Yes - L/U
NIHB	Biologics and Biosimilars	Adalimumab	Abrilada	Yes – L/U	Yes – S/A
NIHB	Biologics and Biosimilars	Adalimumab	Simlandi	Yes - L/U	Yes - L/U
NIHB	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes - L/U	Yes - L/U
NIHB	Systemic Drugs	Apremilast	Otezla®	Yes	No
NIHB	Biologics and Biosimilars	Bimekizumab	Bimzelx	No	No
NIHB	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – L/U	N/A
NIHB	Systemic Drugs	Celecoxib	Celebrex	N/A	Yes
NIHB	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – L/U
NIHB	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
NIHB	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
NIHB	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
NIHB	Systemic Drugs	Cyclosporine	Cyclosporine	Yes	Yes
NIHB	Biologics and Biosimilars	Etanercept	Enbrel®	No	Yes- Only for clients who received approval for Enbrel before October 2, 2017
NIHB	Biologics and Biosimilars	Etanercept	Erelzi™	No	Yes- L/U
NIHB	Biologics and Biosimilars	Etanercept	Brenzys®	No	Yes - L/U
NIHB	Biologics and Biosimilars	Etanercept	Rymti	No	Yes - L/U
NIHB	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – L/U
NIHB	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes - L/U	Yes - L/U
NIHB	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes	N/A
NIHB	Biologics and Biosimilars	Infliximab	Remicade®	No	No
NIHB	Biologics and Biosimilars	Infliximab	Avsola®	Yes - L/U	Yes - L/U
NIHB	Biologics and Biosimilars	Infliximab	Inflectra®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Northwest Territories	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
Northwest Territories	Biologics and Biosimilars	Adalimumab	Humira®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Adalimumab	Abrilada	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Adalimumab	Simlandi	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes - L/U	Yes - L/U
Northwest Territories	Systemic Drugs	Apremilast	Otezla®	Yes - L/U	No
Northwest Territories	Biologics and Biosimilars	Bimekizumab	Bimzelx	No	No
Northwest Territories	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – L/U	N/A
Northwest Territories	Systemic Drugs	Celecoxib	Celebrex	N/A	Yes
Northwest Territories	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – L/U
Northwest Territories	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
Northwest Territories	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
Northwest Territories	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
Northwest Territories	Systemic Drugs	Cyclosporine		Yes	Yes
Northwest Territories	Biologics and Biosimilars	Etanercept	Enbrel®	No	Yes – L/U
Northwest Territories	Biologics and Biosimilars	Etanercept	Erelzi™	Yes- L/U	Yes – L/U
Northwest Territories	Biologics and Biosimilars	Etanercept	Brenzys®	No	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Etanercept	Rymti	No	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – L/U
Northwest Territories	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes - L/U	Yes - L/U
Northwest Territories	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes	N/A
Northwest Territories	Biologics and Biosimilars	Infliximab	Remicade®	No	No
Northwest Territories	Biologics and Biosimilars	Infliximab	Avsola®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – L/U	Yes – L/U
Nova Scotia	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Nova Scotia	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
Nova Scotia	Biologics and Biosimilars	Adalimumab	Humira®	Yes- only for clients who received approval for Humira before December 15, 2021	Yes- only for clients who received approval for Humira before December 15, 2021
Nova Scotia	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Adalimumab	Idacio®	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Adalimumab	Hulio®	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Adalimumab	Abrilada	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Adalimumab	Simlandi	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes – EDS	Yes – EDS
Nova Scotia	Systemic Drugs	Apremilast	Otezla®	Yes	Yes
Nova Scotia	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes – EDS	No
Nova Scotia	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – EDS	N/A
Nova Scotia	Systemic Drugs	Celecoxib	Celebrex	N/A	No
Nova Scotia	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – EDS
Nova Scotia	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes – EDS	N/A
Nova Scotia	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	No	N/A
Nova Scotia	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes – EDS	N/A
Nova Scotia	Systemic Drugs	Cyclosporine		Yes	N/A
Nova Scotia	Biologics and Biosimilars	Etanercept	Enbrel®	Yes – EDS; for etanercept-naïve patients whose etanercept therapy is initiated after Nov 1, 2017, a biosimilar will be the product that is approved.	Yes – EDS; for etanercept-naïve patients whose etanercept therapy is initiated after Nov 1, 2017, a biosimilar will be the product that is approved.
Nova Scotia	Biologics and Biosimilars	Etanercept	Erelzi™	No	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Etanercept	Brenzys®	Yes - EDS	Yes - EDS
Nova Scotia	Biologics and Biosimilars	Etanercept	Rymti	Yes - EDS	Yes - EDS
Nova Scotia	Biologics and Biosimilars	Golimumab	Simponi®	No	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes – EDS	Yes – EDS
Nova Scotia	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	No	N/A
Nova Scotia	Biologics and Biosimilars	Infliximab	Remicade®	Yes – S/A. For infliximab naïve patients whose infliximab therapy is initiated after June 1, 2016, an infliximab biosimilar will be the product approved.	Yes – S/A. For infliximab naïve patients whose infliximab therapy is initiated after June 1, 2016, an infliximab biosimilar will be the product approved.
Nova Scotia	Biologics and Biosimilars	Infliximab	Avsola®	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – EDS	Yes – EDS
Nunavut	Biologics and Biosimilars	Adalimumab	Abrilada	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - L/U	Yes - L/U
Nunavut	Systemic Drugs	Leflunomide	Arava®	N/A	Yes
Nunavut	Biologics and Biosimilars	Infliximab	Avsola®	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Bimekizumab	Bimzelx	No	No
Nunavut	Biologics and Biosimilars	Etanercept	Brenzys®	No	Yes - L/U
Nunavut	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Nunavut	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
Nunavut	Systemic Drugs	Celecoxib	Celebrex	N/A	Yes
Nunavut	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – L/U
Nunavut	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – L/U	Yes – L/U
Nunavut	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
Nunavut	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
Nunavut	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes	N/A
Nunavut	Biologics and Biosimilars	Etanercept	Enbrel®	No	Yes – L/U
Nunavut	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
Nunavut	Biologics and Biosimilars	Etanercept	Erelzi™	Yes- L/U	Yes – L/U
Nunavut	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Adalimumab	Humira®	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Tildrakizumab	Ilumya™	No	N/A
Nunavut	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – L/U	Yes – L/U
Nunavut	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Nunavut	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Nunavut	Systemic Drugs	Apremilast	Otezla®	Yes	No
Nunavut	Biologics and Biosimilars	Infliximab	Remicade®	No	No
Nunavut	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Nunavut	Biologics and Biosimilars	Infliximab	Renflexis®	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Abatacept	Orencia®	N/A	No. EAP may cover in specific clinical circumstances.
Ontario	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
Ontario	Biologics and Biosimilars	Adalimumab	Abrilada	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Adalimumab	Humira®	Yes - EAP	Yes - EAP
Ontario	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Adalimumab	Simlandi	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes - L/U	Yes - L/U
Ontario	Systemic Drugs	Apremilast	Otezla®	Yes	Yes
Ontario	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes - L/U	No
Ontario	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – L/U	N/A
Ontario	Systemic Drugs	Celecoxib	Celebrex	N/A	No
Ontario	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – EAP
Ontario	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes – in specific clinical situations	N/A
Ontario	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes – in specific clinical situations	N/A
Ontario	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes – in specific clinical situations	N/A
Ontario	Systemic Drugs	Cyclosporine		Yes	N/A
Ontario	Biologics and Biosimilars	Etanercept	Brenzys®	Yes – L/U	Yes – L/U
Ontario	Biologics and Biosimilars	Etanercept	Enbrel®	Yes - EAP	Yes - EAP
Ontario	Biologics and Biosimilars	Etanercept	Erelzi™	Yes – L/U	Yes – L/U
Ontario	Biologics and Biosimilars	Etanercept	Rymti	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes - EAP
Ontario	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes - L/U	Yes - EAP
Ontario	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes	N/A
Ontario	Biologics and Biosimilars	Infliximab	Avsola®	Yes – L/U	Yes – L/U
Ontario	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – L/U	Yes – L/U
Ontario	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Prince Edward Island	Biologics and Biosimilars	Abatacept	Orencia®	No	No
27 June, 2024	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Humira®	Yes - S/A	Yes - S/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Idacio®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - S/A	Yes - S/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Hulio®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Abrilada	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Simlandi	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes – S/A	Yes – S/A
Prince Edward Island	Systemic Drugs	Apremilast	Otezla®	No	No
Prince Edward Island	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes – S/A	No
Prince Edward Island	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – S/A	N/A
Prince Edward Island	Systemic Drugs	Celecoxib		N/A	Yes
Prince Edward Island	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – S/A
Prince Edward Island	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
Prince Edward Island	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
Prince Edward Island	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
Prince Edward Island	Systemic Drugs	Cyclosporine		Yes	N/A
Prince Edward Island	Biologics and Biosimilars	Etanercept	Enbrel®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Etanercept	Erelzi™	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Etanercept	Brenzys®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Golimumab	Simponi®	No	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes – S/A	Yes – S/A
Prince Edward Island	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	No	N/A
Prince Edward Island	Biologics and Biosimilars	Infliximab	Remicade®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Infliximab	Avsola®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Quebec	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
Quebec	Biologics and Biosimilars	Adalimumab	Humira®	Yes - S/A. If treatment began before August 19, 2020.	Yes - S/A. If treatment began before August 19, 2020.
Quebec	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - S/A	Yes - S/A
Quebec	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Adalimumab	Idacio®	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Adalimumab	Hulio®	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Adalimumab	Abrilada	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Adalimumab	Simlandi	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes – S/A	Yes – S/A
Quebec	Systemic Drugs	Apremilast	Otezla®	Yes – S/A	No
Quebec	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes – S/A	No
Quebec	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – S/A	N/A
Quebec	Systemic Drugs	Celecoxib	Celebrex	N/A	Yes
Quebec	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – S/A
Quebec	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes – S/A	N/A
Quebec	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes – S/A	N/A
Quebec	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes – S/A	N/A
Quebec	Systemic Drugs	Cyclosporine		Yes	N/A
Quebec	Biologics and Biosimilars	Etanercept	Enbrel®	Yes – S/A. If treatment began before August 19, 2020	Yes – S/A. If treatment began before August 19, 2020
Quebec	Biologics and Biosimilars	Etanercept	Erelzi™	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Etanercept	Brenzys®	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Etanercept	Rymti	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – S/A
Quebec	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes - S/A	No
Quebec	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes - S/A	N/A
Quebec	Biologics and Biosimilars	Infliximab	Remicade®	Yes – S/A. If treatment began before August 19, 2020	Yes – S/A. If treatment began before August 19, 2020
Quebec	Biologics and Biosimilars	Infliximab	Avsola®	Yes - S/A	Yes - S/A
Quebec	Biologics and Biosimilars	Infliximab	Inflectra®	Yes - S/A	Yes - S/A
Saskatchewan	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Saskatchewan	Systemic Drugs	Acitretin	Soriatane®	Yes – EDS	N/A
Saskatchewan	Biologics and Biosimilars	Adalimumab	Humira®	No	No
Saskatchewan	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Adalimumab	Idacio®	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Adalimumab	Hulio®	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Adalimumab	Abrilada	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Adalimumab	Simlandi	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes – EDS	Yes – EDS
Saskatchewan	Systemic Drugs	Apremilast	Otezla®	No	No
Saskatchewan	Biologics and Biosimilars	Bimekizumab	Bimzelx	Yes - EDS	No
Saskatchewan	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – EDS	No
Saskatchewan	Systemic Drugs	Celecoxib	Celebrex	Yes	Yes
Saskatchewan	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – EDS
Saskatchewan	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
Saskatchewan	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
Saskatchewan	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
Saskatchewan	Systemic Drugs	Cyclosporine		Yes – EDS	N/A
Saskatchewan	Biologics and Biosimilars	Etanercept	Enbrel®	No	No
Saskatchewan	Biologics and Biosimilars	Etanercept	Erelzi™	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Etanercept	Brenzys®	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Golimumab	Simponi®	No	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes - EDS	Yes - EDS
Saskatchewan	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	Yes	N/A
Saskatchewan	Biologics and Biosimilars	Infliximab	Remicade®	No	No
Saskatchewan	Biologics and Biosimilars	Infliximab	Avsola®	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Infliximab	Inflectra®	Yes – EDS	Yes – EDS
Yukon	Biologics and Biosimilars	Abatacept	Orencia®	No	No
Yukon	Systemic Drugs	Acitretin	Soriatane®	Yes – EDS	N/A
Yukon	Biologics and Biosimilars	Adalimumab	Humira®	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Adalimumab	Hadlima®	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Adalimumab	Hyrimoz®	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Adalimumab	Idacio®	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Adalimumab	Amgevita®	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Adalimumab	Hulio®	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Adalimumab	Abrilada	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Adalimumab	Simlandi	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes - EDS	Yes - EDS
Yukon	Systemic Drugs	Apremilast	Otezla®	No	No
Yukon	Biologics and Biosimilars	Bimekizumab	Bimzelx	No	No
Yukon	Biologics and Biosimilars	Brodalumab	Siliq™	No	N/A
Yukon	Systemic Drugs	Celecoxib		N/A	Yes
Yukon	Biologics and Biosimilars	Certolizumab pegol	Cimzia®	No	Yes – EDS
Yukon	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Gel	Yes	N/A
Yukon	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Dovobet®_Ointment	Yes	N/A
Yukon	Prescription Topical Treatments	Combination Vitamin D3 Analogues and Corticosteroids	Enstilar™_Foam	Yes	N/A
Yukon	Systemic Drugs	Cyclosporine		Yes	N/A
Yukon	Biologics and Biosimilars	Etanercept	Enbrel®	Yes - EDS ; all new etanercept patients will be covered for Brenzys or Erelzi	Yes – EDS; all new etanercept patients will be covered for Erelzi
Yukon	Biologics and Biosimilars	Etanercept	Erelzi™	Yes - EDS	Yes – EDS
Yukon	Biologics and Biosimilars	Etanercept	Brenzys®	Yes - EDS	Yes – EDS
Yukon	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – EDS
Yukon	Biologics and Biosimilars	Guselkumab	Tremfya®	No	No
Yukon	Prescription Topical Treatments	Halobetasol propionate and tazarotene	DUOBRII®	No	N/A
Yukon	Biologics and Biosimilars	Infliximab	Remicade®	Yes – EDS; all new infliximab patients will be covered for Inflectra brand only.	Yes – EDS; all new infliximab patients will be covered for Inflectra brand only.
Yukon	Biologics and Biosimilars	Infliximab	Avsola®	No	No
Yukon	Biologics and Biosimilars	Infliximab	Inflectra®	Yes - EDS	Yes - EDS
Alberta	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Alberta	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Alberta	Biologics and Biosimilars	Infliximab	Renflexis®	Yes – S/A	Yes – S/A
Alberta	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – S/A	Yes – S/A
Alberta	Systemic Drugs	Leflunomide	Arava®	No	No
Alberta	Systemic Drugs	Methotrexate		Yes	Yes
Alberta	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – S/A	N/A
British Columbia	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
British Columbia	Biologics and Biosimilars	Infliximab	Remsima™	No	No
British Columbia	Biologics and Biosimilars	Infliximab	Renflexis®	Yes – S/A	Yes – S/A
British Columbia	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – S/A	Yes – S/A
British Columbia	Systemic Drugs	Leflunomide	Arava®	Yes	Yes
British Columbia	Systemic Drugs	Methotrexate		Yes	Yes
British Columbia	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – S/A	N/A
Manitoba	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Manitoba	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Manitoba	Biologics and Biosimilars	Infliximab	Renflexis®	Yes – EDS	Yes – EDS
Manitoba	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – EDS	Yes – EDS
Manitoba	Biologics and Biosimilars	Ixekizumab	Siliq™	Yes – EDS	N/A
Manitoba	Systemic Drugs	Leflunomide	Arava®	No	No
Manitoba	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – EDS	N/A
New Brunswick	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
New Brunswick	Biologics and Biosimilars	Infliximab	Remsima™	No	No
New Brunswick	Biologics and Biosimilars	Infliximab	Renflexis®	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – S/A	Yes – S/A
New Brunswick	Systemic Drugs	Leflunomide	Arava®	N/A	Yes
New Brunswick	Systemic Drugs	Methotrexate		Yes	Yes
New Brunswick	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – S/A	N/A
Newfoundland and Labrador	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Newfoundland and Labrador	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Newfoundland and Labrador	Biologics and Biosimilars	Infliximab	Renflexis®	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Systemic Drugs	Leflunomide	Arava®	N/A	Yes
Newfoundland and Labrador	Systemic Drugs	Methotrexate		Yes	Yes
Newfoundland and Labrador	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – S/A	N/A
NIHB	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
NIHB	Biologics and Biosimilars	Infliximab	Remsima™	No	No
NIHB	Biologics and Biosimilars	Infliximab	Renflexis®	Yes - L/U	Yes - L/U
NIHB	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – L/U	Yes – L/U
NIHB	Systemic Drugs	Leflunomide	Arava®	Yes	Yes
NIHB	Systemic Drugs	Methotrexate		Yes	Yes
NIHB	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – L/U	N/A
Northwest Territories	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Northwest Territories	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Northwest Territories	Biologics and Biosimilars	Infliximab	Renflexis®	Yes - L/U	Yes - L/U
Northwest Territories	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – L/U	Yes – L/U
Northwest Territories	Systemic Drugs	Leflunomide	Arava®	N/A	Yes
Northwest Territories	Systemic Drugs	Methotrexate		Yes	Yes
Northwest Territories	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – L/U	N/A
Nova Scotia	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Nova Scotia	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Nova Scotia	Biologics and Biosimilars	Infliximab	Renflexis®	Yes – EDS	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – EDS	Yes – EDS
Nova Scotia	Systemic Drugs	Leflunomide	Arava®	N/A	Yes
Nova Scotia	Systemic Drugs	Methotrexate		Yes	Yes
Nova Scotia	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – EDS	N/A
Nunavut	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	No
Nunavut	Biologics and Biosimilars	Etanercept	Rymti	No	Yes - L/U
Nunavut	Biologics and Biosimilars	Brodalumab	Siliq™	Yes – L/U	N/A
Nunavut	Biologics and Biosimilars	Adalimumab	Simlandi	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Golimumab	Simponi®	N/A	Yes – L/U
Nunavut	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – L/U	N/A
Nunavut	Systemic Drugs	Acitretin	Soriatane®	Yes	N/A
Ontario	Biologics and Biosimilars	Infliximab	Remicade®	Yes - EAP	Yes - EAP
Ontario	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Ontario	Biologics and Biosimilars	Infliximab	Renflexis®	Yes – L/U	Yes – L/U
Ontario	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – L/U	Yes - EAP
Ontario	Systemic Drugs	Leflunomide	Arava®	Yes	Yes
Ontario	Systemic Drugs	Methotrexate		Yes	Yes
Ontario	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – L/U	N/A
Prince Edward Island	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Prince Edward Island	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Prince Edward Island	Biologics and Biosimilars	Infliximab	Renflexis®	Yes – S/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – S/A	Yes – S/A
Prince Edward Island	Systemic Drugs	Leflunomide	Arava®	N/A	Yes
Prince Edward Island	Systemic Drugs	Methotrexate		Yes	Yes
Prince Edward Island	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – S/A	N/A
Quebec	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Quebec	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Quebec	Biologics and Biosimilars	Infliximab	Renflexis®	Yes - S/A	Yes - S/A
Quebec	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – S/A	Yes – S/A
Quebec	Systemic Drugs	Leflunomide	Arava®	N/A	Yes
Quebec	Systemic Drugs	Methotrexate		Yes	Yes
Quebec	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – S/A	N/A
Saskatchewan	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Saskatchewan	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Saskatchewan	Biologics and Biosimilars	Infliximab	Renflexis®	Yes – EDS	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – EDS	Yes – EDS
Saskatchewan	Systemic Drugs	Leflunomide	Arava®	No	Yes – EDS
Saskatchewan	Systemic Drugs	Methotrexate		Yes	Yes
Saskatchewan	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – EDS	N/A
Yukon	Biologics and Biosimilars	Infliximab	Omvyence™	No	No
Yukon	Biologics and Biosimilars	Infliximab	Remsima™	No	No
Yukon	Biologics and Biosimilars	Infliximab	Renflexis®	Yes - EDS	Yes - EDS
Yukon	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes - EDS	Yes - EDS
Yukon	Systemic Drugs	Leflunomide	Arava®	No	No
Yukon	Systemic Drugs	Methotrexate		Yes	Yes
Yukon	Biologics and Biosimilars	Risankizumab	Skyrizi™	Yes – EDS	N/A
Alberta	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – S/A	Yes – S/A
Alberta	Systemic Drugs	Sulfasalazine		Yes	Yes
Alberta	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes - SA	N/A
Alberta	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
Alberta	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes	N/A
Alberta	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes – S/A
Alberta	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – S/A	No
Alberta	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes – S/A	No
Alberta	Biologics and Biosimilars	Ustekinumab	Jamteki	Yes – S/A	No
Alberta	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Alberta	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
British Columbia	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – S/A	Yes – S/A
British Columbia	Systemic Drugs	Sulfasalazine	Salazopyrin	Yes	Yes
British Columbia	Biologics and Biosimilars	Tildrakizumab	Ilumya™	No	N/A
British Columbia	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
British Columbia	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes	N/A
British Columbia	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	No
British Columbia	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – S/A until Dec 3 2024	No
British Columbia	Biologics and Biosimilars	Ustekinumab	Jamteki	Yes - S/A	Yes - S/A
British Columbia	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
British Columbia	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
Manitoba	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – EDS	Yes – EDS
Manitoba	Systemic Drugs	Sulfasalazine	pms-Sulfasalazine, Salazopyrin	Yes	Yes
Manitoba	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes - EDS	N/A
Manitoba	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
Manitoba	Prescription Topical Treatments	Topical Retinoids	Tazarotene	No	N/A
Manitoba	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes - EDS
Manitoba	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – EDS	No
Manitoba	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Manitoba	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
New Brunswick	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – S/A	Yes – S/A
New Brunswick	Systemic Drugs	Sulfasalazine	Salazopyrin	N/A	Yes
New Brunswick	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes - SA	N/A
New Brunswick	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
New Brunswick	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes – S/A	N/A
New Brunswick	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes – S/A
New Brunswick	Biologics and Biosimilars	Ustekinumab	Stelara®	No	No
New Brunswick	Biologics and Biosimilars	Ustekinumab	Jamteki	Yes - S/A	Yes - S/A
New Brunswick	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes - S/A	Yes - S/A
New Brunswick	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
New Brunswick	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	Yes	N/A
Newfoundland and Labrador	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Systemic Drugs	Sulfasalazine		N/A	Yes
Newfoundland and Labrador	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes – S/A	N/A
Newfoundland and Labrador	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
Newfoundland and Labrador	Prescription Topical Treatments	Topical Retinoids	Tazarotene	No	N/A
Newfoundland and Labrador	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes – S/A
Newfoundland and Labrador	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – S/A	No
Newfoundland and Labrador	Biologics and Biosimilars	Ustekinumab	Jamteki	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes – S/A	Yes – S/A
Newfoundland and Labrador	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Newfoundland and Labrador	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
NIHB	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – L/U	Yes – L/U
NIHB	Systemic Drugs	Sulfasalazine		Yes	Yes
NIHB	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes – L/U	N/A
NIHB	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
NIHB	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes	N/A
NIHB	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes- L/U
NIHB	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – L/U	No
NIHB	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes - L/U	Yes - L/U
NIHB	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
NIHB	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
Northwest Territories	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – L/U	Yes – L/U
Northwest Territories	Systemic Drugs	Sulfasalazine		N/A	Yes
Northwest Territories	Biologics and Biosimilars	Tildrakizumab	Ilumya™	No	N/A
Northwest Territories	Systemic Drugs	Tofacitinib	Xeljanz®	No	No
Northwest Territories	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes	N/A
Northwest Territories	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	No
Northwest Territories	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – L/U	No
Northwest Territories	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes – L/U	Yes – L/U
Northwest Territories	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Northwest Territories	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
Nova Scotia	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – EDS	Yes - EDS
Nova Scotia	Systemic Drugs	Sulfasalazine		N/A	Yes
Nova Scotia	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes – EDS	N/A
Nova Scotia	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
Nova Scotia	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes – EDS	N/A
Nova Scotia	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes – EDS
Nova Scotia	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes - EDS	No
Nova Scotia	Biologics and Biosimilars	Ustekinumab	Jamteki	Yes - EDS	Yes - EDS
Nova Scotia	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes - EDS	Yes - EDS
Nova Scotia	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes - EDS	N/A
Nova Scotia	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	Yes	N/A
Nunavut	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – L/U	No
Nunavut	Biologics and Biosimilars	Ixekizumab	Taltz®	Yes – L/U	Yes – L/U
Nunavut	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes	N/A
Nunavut	Biologics and Biosimilars	Guselkumab	Tremfya®	Yes - L/U	Yes - L/U
Nunavut	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes – L/U	Yes – L/U
Nunavut	Systemic Drugs	Tofacitinib	Xeljanz®	No	No
Nunavut	Biologics and Biosimilars	Adalimumab	Yuflyma	Yes - L/U	Yes - L/U
Nunavut	Systemic Drugs	Cyclosporine		Yes	Yes
Nunavut	Systemic Drugs	Methotrexate		Yes	Yes
Nunavut	Systemic Drugs	Sulfasalazine		N/A	Yes
Ontario	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – L/U	Yes - EAP
Ontario	Systemic Drugs	Sulfasalazine		N/A	Yes
Ontario	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes - L/U	N/A
Ontario	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
Ontario	Prescription Topical Treatments	Topical Retinoids	Tazarotene	No	N/A
Ontario	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	No
Ontario	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – L/U	No
Ontario	Biologics and Biosimilars	Ustekinumab	Jamteki	Yes - L/U	Yes - L/U
Ontario	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes - L/U	Yes - L/U
Ontario	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes – L/U	N/A
Ontario	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	Yes – L/U	N/A
Prince Edward Island	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – S/A	Yes – S/A
Prince Edward Island	Systemic Drugs	Sulfasalazine		N/A	Yes
Prince Edward Island	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes – S/A	N/A
Prince Edward Island	Systemic Drugs	Tofacitinib	Xeljanz®	No	No
Prince Edward Island	Prescription Topical Treatments	Topical Retinoids	Tazarotene	No	N/A
Prince Edward Island	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes – S/A
Prince Edward Island	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – S/A	No
Prince Edward Island	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Prince Edward Island	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
Quebec	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – S/A	Yes – S/A
Quebec	Systemic Drugs	Sulfasalazine		N/A	Yes
Quebec	Biologics and Biosimilars	Tildrakizumab	Ilumya™	No	N/A
Quebec	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
Quebec	Prescription Topical Treatments	Topical Retinoids	Tazarotene	No	N/A
Quebec	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes – S/A
Quebec	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Ustekinumab	Jamteki	Yes – S/A	Yes – S/A
Quebec	Biologics and Biosimilars	Ustekinumab	Wezlana	Yes – S/A	Yes – S/A
Quebec	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Quebec	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	Yes	N/A
Saskatchewan	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – EDS	Yes – EDS
Saskatchewan	Systemic Drugs	Sulfasalazine		N/A	Yes
Saskatchewan	Biologics and Biosimilars	Tildrakizumab	Ilumya™	Yes - EDS	N/A
Saskatchewan	Systemic Drugs	Tofacitinib	Xeljanz®	N/A	No
Saskatchewan	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes	N/A
Saskatchewan	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	Yes – EDS
Saskatchewan	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – EDS	Yes – EDS
Saskatchewan	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Saskatchewan	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	No	N/A
Yukon	Biologics and Biosimilars	Secukinumab	Cosentyx®	Yes – EDS	Yes – EDS
Yukon	Systemic Drugs	Sulfasalazine		N/A	Yes
Yukon	Biologics and Biosimilars	Tildrakizumab	Ilumya™	No	N/A
Yukon	Systemic Drugs	Tofacitinib	Xeljanz®	No	No
Yukon	Prescription Topical Treatments	Topical Retinoids	Tazarotene	Yes	N/A
Yukon	Systemic Drugs	Upadacitinib	Rinvoq®	N/A	No
Yukon	Biologics and Biosimilars	Ustekinumab	Stelara®	Yes – EDS	No
Yukon	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcipotriol - Dovonex®	Yes	N/A
Yukon	Prescription Topical Treatments	Vitamin_D3_Analogues(Dovonex® Silkis®)	Calcitriol - Silkis®	Yes	N/A

More information is available on S/A (special access), L/U (limited use) and Exceptional Drug Status (EDS) at Special Access / Limited Use Designation Drugs.

NIHB stands for non-insured health benefits.

This site is updated regularly; however this information is subject to change. Access may also vary depending on the specific plan. For the most up-to-date information regarding your specific province / territory click here.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Public Drug Program Formulary Tables – Psoriasis and Psoriatic Arthritis

Manage Cookies